STOK — Stoke Therapeutics Inc

Ownership history in Siren, L.L.C.  ·  5 quarters on record

This page tracks every 13F SEC filing in which Siren, L.L.C. reported a position in Stoke Therapeutics Inc (STOK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.13% (2025 Q4)
Avg. % of fund
1.47%
First filed
2024 Q4
Last filed
2025 Q4
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 2,247,347 — 0% 2.13% $71.3M $31.74
2025 Q3 UNCHANGED 2,247,347 — 0% 2.07% $52.8M $23.50
2025 Q2 UNCHANGED 2,247,347 — 0% 1.32% $25.5M $11.35
2025 Q1 ADDED 2,247,347 +247,347 +12.4% 0.85% $14.9M $6.65
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    STOK price (monthly, adj. close)

Other funds also holding STOK

As of 2025 Q4 — sorted by position size

Lynx1 Capital Management LP 3Y 34.73% Redmile Group, LLC 3Y 7Y 9.43% Birchview Capital, LP 3Y 7Y 4.83% Opaleye Management Inc. 3Y 7Y 2.91% MPM BioImpact LLC 3Y 2.8% BVF INC/IL 3Y 7Y 2.42% RTW INVESTMENTS, LP 3Y 7Y 1.76% Quantedge Capital Pte Ltd 3Y 1.32% Parkman Healthcare Partners LLC 3Y 1.3% HighVista Strategies LLC 3Y 7Y 0.94%
← Back to Siren, L.L.C. Holdings